ImmuneOnco Biopharmaceuticals Has Received A Near-Term Payment Of $5M From Instil Bio's SynBioTx, Bringing The Total Received Under Their License And Collaboration Agreement To $15M, With Potential Future Payments Up To $35M Expected
Benzinga Newsdesk 2 years ago
BiotechNewsContractsGeneral
https://www1.hkexnews.hk/listedco/listconews/sehk/2024/0911/2024091100005.pdf